Literature DB >> 20470216

Bone marrow CD34+ cells expanded on human brain endothelial cells reconstitute lethally irradiated baboons in a variable manner.

Hiroto Araki1, John P Chute, Benjamin Petro, Lisa Halliday, Ronald Hoffman, Nadim Mahmud.   

Abstract

Increased cell dose has a positive impact on the therapeutic outcome of bone marrow (BM) hematopoietic stem cell (HSC) transplant. However, methods to successfully expand BM HSCs have yet to be achieved. It has been shown previously that ex vivo expansion of BM cells using porcine microvascular endothelial cells can rescue a baboon from a lethal dose of radiation. However, in a prior study, baboons that received CD34+ cell doses less than 4 x 10(6) cells/kg body weight failed to achieve hematopoietic reconstitution. In our present study we used human brain endothelial cells (HUBECs) and cytokines to expand BM cells, and examined their ability to provide hematopoietic reconstitution in three lethally irradiated baboons following autologous transplant as a surrogate preclinical model. After ex vivo culture, the grafts represented a 1.8- to 2.1-fold expansion of CD34+ cells, a 3.7- to 13.2-fold increase of colony-forming cells, and a 1.9- to 3.2-fold increase of cobblestone area-forming cells, in comparison to the input cell numbers. Despite transplanting CD34+ cell grafts displaying a comparable degree of expansion, there was an obvious variability in the kinetics of hematopoietic reconstitution. The variation in hematopoietic reconstitution cannot be fully explained by the properties tested in expanded CD34+ cells, and warrant caution against taking into account such attributes as cell dose, expression of adhesion molecules, and migration as a measure of successful expansion of HSCs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20470216     DOI: 10.3109/10428191003786774

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  2 in total

1.  Endothelial Cells Promote Expansion of Long-Term Engrafting Marrow Hematopoietic Stem and Progenitor Cells in Primates.

Authors:  Jennifer L Gori; Jason M Butler; Balvir Kunar; Michael G Poulos; Michael Ginsberg; Daniel J Nolan; Zachary K Norgaard; Jennifer E Adair; Shahin Rafii; Hans-Peter Kiem
Journal:  Stem Cells Transl Med       Date:  2016-10-14       Impact factor: 6.940

2.  Preclinical IV busulfan dose-finding study to induce reversible myeloablation in a non-human primate model.

Authors:  Nadim Mahmud; Amit Khanal; Simona Taioli; Emre Koca; Sujata Gaitonde; Benjamin Petro; Karen Sweiss; Lisa Halliday; Xinhe Wang; Pritesh Patel; Damiano Rondelli
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.